VRXA insider trades & Congress trades
Veraxa Biotech AG - Post de-SPAC: public insider filings and Congress disclosures, in one place.
Bourse has recorded 6 open-market insider transactions in Veraxa Biotech AG - Post de-SPAC (VRXA) (6 purchases with code P and 0 sales with code S), the most recent on October 28, 2026.
In the last 90 days: 6 purchases by 5 insiders ($135K) and 0 sales by 0 ($0).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Oct 28, 2026 | Gruninger Marc | – | Buy | 9,133 | $1.00 | $9K | – |
| Oct 27, 2026 | Gruninger Marc | – | Buy | 867 | $0.98 | $850 | – |
| Oct 20, 2026 | Ziegler Christoph Samuel | – | Buy | 30,000 | $1.09 | $33K | – |
| Sep 10, 2026 | Hosseinion Warren | President | Buy | 6,024 | $1.67 | $10K | −0.3% |
| Aug 27, 2026 | Baumann Oliver Rolf | – | Buy | 50,000 | $1.50 | $75K | −0.1% |
| Aug 27, 2026 | Antz Christoph Rudiger | Chief Executive Officer | Buy | 5,000 | $1.53 | $8K | −0.1% |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.